MCRB Annual Operating Expenses
$234.31 M
-$19.31 M-7.61%
31 December 2023
Summary:
As of January 23, 2025, MCRB annual total operating expenses is $234.31 million, with the most recent change of -$19.31 million (-7.61%) on December 31, 2023. During the last 3 years, it has risen by +$112.96 million (+93.09%). MCRB annual operating expenses is now -7.61% below its all-time high of $253.62 million, reached on December 31, 2022.MCRB Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MCRB Quarterly Operating Expenses
$29.17 M
-$2.17 M-6.94%
30 September 2024
Summary:
As of January 23, 2025, MCRB quarterly total operating expenses is $29.17 million, with the most recent change of -$2.17 million (-6.94%) on September 30, 2024. Over the past year, it has dropped by -$47.06 million (-61.74%). MCRB quarterly operating expenses is now -62.09% below its all-time high of $76.95 million, reached on June 30, 2023.MCRB Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MCRB Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -7.6% | -61.7% |
| 3 y3 years | +93.1% | -57.9% |
| 5 y5 years | +82.3% | -57.9% |
MCRB Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -7.6% | +11.9% | -62.1% | at low |
| 5 y | 5-year | -7.6% | +123.4% | -62.1% | +9.7% |
| alltime | all time | -7.6% | +7625.3% | -62.1% | +1644.6% |
Seres Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $29.17 M(-6.9%) |
| June 2024 | - | $31.34 M(-20.8%) |
| Mar 2024 | - | $39.59 M(-48.1%) |
| Dec 2023 | $234.31 M(-7.6%) | $76.23 M(+71.0%) |
| Sept 2023 | - | $44.59 M(-42.1%) |
| June 2023 | - | $76.95 M(+9.9%) |
| Mar 2023 | - | $70.05 M(+1.1%) |
| Dec 2022 | $253.62 M(+21.1%) | $69.28 M(+10.8%) |
| Sept 2022 | - | $62.55 M(-3.1%) |
| June 2022 | - | $64.54 M(+12.7%) |
| Mar 2022 | - | $57.24 M(-0.8%) |
| Dec 2021 | $209.42 M(+72.6%) | $57.72 M(-1.0%) |
| Sept 2021 | - | $58.32 M(+9.2%) |
| June 2021 | - | $53.41 M(+30.1%) |
| Mar 2021 | - | $41.04 M(+15.7%) |
| Dec 2020 | $121.34 M(+15.7%) | $35.46 M(+12.9%) |
| Sept 2020 | - | $31.41 M(+18.1%) |
| June 2020 | - | $26.59 M(-4.6%) |
| Mar 2020 | - | $27.88 M(+4.0%) |
| Dec 2019 | $104.89 M | $26.81 M(+10.7%) |
| Sept 2019 | - | $24.21 M(+3.1%) |
| June 2019 | - | $23.48 M(-22.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $30.38 M(-5.9%) |
| Dec 2018 | $128.55 M(+4.1%) | $32.30 M(+3.3%) |
| Sept 2018 | - | $31.27 M(-4.5%) |
| June 2018 | - | $32.75 M(+1.6%) |
| Mar 2018 | - | $32.24 M(-1.8%) |
| Dec 2017 | $123.50 M(+7.8%) | $32.83 M(+8.2%) |
| Sept 2017 | - | $30.33 M(-3.5%) |
| June 2017 | - | $31.43 M(+8.7%) |
| Mar 2017 | - | $28.91 M(+0.7%) |
| Dec 2016 | $114.61 M(+108.9%) | $28.71 M(-10.6%) |
| Sept 2016 | - | $32.11 M(+3.1%) |
| June 2016 | - | $31.14 M(+37.6%) |
| Mar 2016 | - | $22.63 M(+14.3%) |
| Dec 2015 | $54.86 M(+263.7%) | $19.79 M(+35.9%) |
| Sept 2015 | - | $14.56 M(+18.0%) |
| June 2015 | - | $12.34 M(+51.1%) |
| Mar 2015 | - | $8.17 M(+13.2%) |
| Dec 2014 | $15.08 M(+149.2%) | $7.21 M(+101.5%) |
| Sept 2014 | - | $3.58 M(+36.7%) |
| June 2014 | - | $2.62 M(+56.6%) |
| Mar 2014 | - | $1.67 M |
| Dec 2013 | $6.05 M(+99.5%) | - |
| Dec 2012 | $3.03 M | - |
FAQ
- What is Seres Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Seres Therapeutics?
- What is Seres Therapeutics annual operating expenses year-on-year change?
- What is Seres Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Seres Therapeutics?
- What is Seres Therapeutics quarterly operating expenses year-on-year change?
What is Seres Therapeutics annual total operating expenses?
The current annual operating expenses of MCRB is $234.31 M
What is the all time high annual operating expenses for Seres Therapeutics?
Seres Therapeutics all-time high annual total operating expenses is $253.62 M
What is Seres Therapeutics annual operating expenses year-on-year change?
Over the past year, MCRB annual total operating expenses has changed by -$19.31 M (-7.61%)
What is Seres Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of MCRB is $29.17 M
What is the all time high quarterly operating expenses for Seres Therapeutics?
Seres Therapeutics all-time high quarterly total operating expenses is $76.95 M
What is Seres Therapeutics quarterly operating expenses year-on-year change?
Over the past year, MCRB quarterly total operating expenses has changed by -$47.06 M (-61.74%)